Abbott Laboratories CDR (ABT)
Market Closed
29 May, 20:00
NEO-L 
XFRA Primary NEO-L CA$
15. 04
-0.15
-0.99%
CA$
- Market Cap
36.49 P/E Ratio
0.28% Div Yield
4,071 Volume
4.44 Eps
CA$ 15.19
Previous Close Want to track ABT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
ABT closed Friday lower at CA$15.04, a decrease of -0.99% from Thursday's close, completing a monthly decrease of -5.82% or -CA$0.93. Over the past 12 months, ABT stock lost -31.76%.
ABT pays dividends to its shareholders, with the most recent payment made on Apr 22, 2026.
The last earnings report, released on Apr 14, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XFRA (EUR).
ABT Chart
Abbott Laboratories CDR (ABT) FAQ
What is the stock price today?
The current price is CA$15.04.
On which exchange is it traded?
Abbott Laboratories CDR is listed on NEO-L.
What is its stock symbol?
The ticker symbol is ABT.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0.28%.
What is its market cap?
As of today, no market cap data is available.
Has Abbott Laboratories CDR ever had a stock split?
No, there has never been a stock split.
Abbott Laboratories CDR Profile
| Pharmaceuticals Industry | Healthcare Sector | Robert Ford CEO | NEO-L Exchange | - ISIN |
| US Country | 114,000 Employees | - Last Dividend | - Last Split | 13 Jan 1978 IPO Date |
Overview
Abbott Laboratories is a global healthcare company that engages in the discovery, development, manufacturing, and sale of a wide range of health care products. With its foundation laid in 1888, and headquartered in North Chicago, Illinois, the company has established a significant presence worldwide. Abbott operates across four main sectors: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices, catering to a diverse range of healthcare needs from generic pharmaceuticals to advanced medical devices.
Products and Services
Abbott Laboratories offers a comprehensive portfolio of products and services across various healthcare domains:
- Generic Pharmaceuticals: Includes treatments for pancreatic exocrine insufficiency, irritable bowel syndrome, biliary spasm, intrahepatic cholestasis, depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease, vestibular vertigo, pain, fever, inflammation, migraine, anti-infective clarithromycin, influenza vaccine, and colon rhythm regulation products.
- Diagnostic Products: Offers laboratory and transfusion medicine systems in areas such as immunoassay, clinical chemistry, hematology, and transfusion. Includes molecular diagnostics for DNA and RNA processing and detection of infectious agents, point-of-care systems, blood gas testing cartridges, rapid diagnostics, molecular point-of-care testing for several diseases, cardiometabolic tests, drug and alcohol tests, remote patient monitoring, consumer self-tests, and laboratory automation and informatics solutions.
- Nutritional Products: Provides nutritional products for both pediatric and adult use, catering to the specific dietary needs of different age groups and health conditions.
- Medical Devices: Offers a wide array of devices for the treatment of cardiovascular diseases, including rhythm management, electrophysiology, heart failure, vascular, and structural heart devices. Additionally, the company develops diabetes care products such as blood glucose monitoring systems, along with neuromodulation devices for managing chronic pain and movement disorders.
Contact Information
Address: 100 Abbott Park Road
Phone: 224 667 6100
Website: https://www.abbott.com
